3-氨基-4-丙基氨基苯甲酸 | 68740-32-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氨基-4-丙基氨基苯甲酸
• 英文名称: 3-amino-4-propylaminobenzoic acid
• 英文别名: 3-amino-4-(propylamino)benzoic acid；3-amino-4-n-propylaminobenzoic acid
• CAS: 68740-32-9
• 化学式: C₁₀H₁₄N₂O₂
• 分子量: 194.233
• InChiKey: NCCPBFIZFBAPTB-UHFFFAOYSA-N

物化性质

• 沸点：
  398.0±37.0 °C(Predicted)
• 密度：
  1.239±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  75.4
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-氨基-4-丙基氨基苯甲酸 在 氯化亚砜 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 21.0h， 生成
  参考文献：
  名称：

  AGENT FOR TREATMENT OR PREVENTION OF DISEASES ASSOCIATED WITH ACTIVITY OF NEUROTROPHIC FACTORS

  摘要：

  公开号：

  EP2436683B1
• 作为产物：
  描述：

  3-硝基-4-丙基氨基苯甲酸 在 镍 溶剂黄146 作用下， 以 甲醇 为溶剂， 生成 3-氨基-4-丙基氨基苯甲酸
  参考文献：
  名称：

  5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives

  摘要：

  具有抗过敏和抗组胺作用的新型5-[4-(二芳基甲基)-1-哌嗪基烷基]苯并咪唑衍生物。

  公开号：

  US04179505A1

文献信息

• (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use
  申请人：Janssen Pharmaceutica N.V.

  公开号：US04859684A1

  公开（公告）日：1989-08-22

  Novel (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives, compositions containing the same, and methods of treating androgen dependent disorders in mammals.

  小说（1H-咪唑-1-基甲基）取代苯并咪唑衍生物，含有该衍生物的组合物，以及治疗哺乳动物雄激素依赖性疾病的方法。
• 5-[4-(Diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives
  申请人：Janssen Pharmaceutica N.V.

  公开号：US04179505A1

  公开（公告）日：1979-12-18

  Novel 5-[4-(diarylmethyl)-1-piperazinylalkyl]benzimidazole derivatives having antiallergic and antihistaminic properties.

  具有抗过敏和抗组胺作用的新型5-[4-(二芳基甲基)-1-哌嗪基烷基]苯并咪唑衍生物。
• Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
  申请人：Ishikawa Junichi

  公开号：US08829035B2

  公开（公告）日：2014-09-09

  A compound depicted by the formula below, or a pharmaceutically acceptable salt or solvate thereof. wherein, R1 represents (1) a C3-6 alkyl group, (2) a C1-6 alkyl group substituted with one or more substituent group(s) selected from those consisting a halogen atom, etc., (3) a C3-10 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group which respectively is optionally substituted with one or more substituent group(s) selected from those consisting an oxo group, etc., (4) an aromatic cyclic hydrocarbon group substituted with one or more substituent selected from the group consisting halogen atom and C1-4 alkoxy group; X represents NH, O, or S; Y represents CH or N; Z represents N or a C—R2; R2 represents (1) hydrogen atom, (2) a C1-6 alkyl group, a C2-6 alkenyl group or a C2-6 alkynyl group that respectively is optionally substituted with one or more substituent group(s) selected from among those consisting (a) a halogen atom, etc., or (3) a C5-6 non-aromatic cyclic hydrocarbon group or a 5- to 6-membered non-aromatic heterocyclic group optionally substituted; ring A represents a benzene ring optionally substituted; ring B represents a benzene ring optionally substituted.

  以下化合物的化学式，或其药学上可接受的盐或溶剂酸盐。其中，R1代表(1) C3-6烷基，(2) C1-6烷基，其上取代有一个或多个取代基，所选取代基包括卤素原子等，(3) C3-10非芳香环烃基或5-至6-成员非芳香杂环基，分别可以选用一个或多个取代基，所选取代基包括氧代基等，(4) 芳香环烃基，其上取代有一个或多个取代基，所选取代基包括卤素原子和C1-4烷氧基；X代表NH、O或S；Y代表CH或N；Z代表N或C—R2；R2代表(1) 氢原子，(2) C1-6烷基、C2-6烯基或C2-6炔基，分别可以选用一个或多个取代基，所选取代基包括卤素原子等，或(3) C5-6非芳香环烃基或5-至6-成员非芳香杂环基，可选用取代基；环A代表一个苯环，可选用取代基；环B代表一个苯环，可选用取代基。
• Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-carbonitriles and their potent activity against candida species
  作者：Hakan Göker、Canan Kuş、David W. Boykin、Sulhiye Yildiz、Nurten Altanlar

  DOI：10.1016/s0968-0896(02)00103-7

  日期：2002.8

  New 2-substituted-phenyl-1H-benzimidazole-5-carboxylic acids (35, 38), ethyl-5-carboxylate (36), -5-carboxamides (37, 39),-5-carboxaldeliyde (42), -5-chloro (40), -5-trifluoromethyl (41), and -5-carbonitriles (44-53, 55-67), -6-carbonitrilc (54) were prepared and evaluated in vitro against Candida species. The cyano substituted compounds 53, 57, 58 and 61 exhibited the greatest activity with MIC values of 3.12 mug/mL, values similar to that of fluconazole. (C) 2002 Elsevier Science Ltd. All rights reserved.
• Design and synthesis of conformationally restricted inhibitors of active thrombin activatable fibrinolysis inhibitor (TAFIa)
  作者：Mikael Brink、Anders Dahlén、Thomas Olsson、Magnus Polla、Tor Svensson

  DOI：10.1016/j.bmc.2014.02.010

  日期：2014.4

  A series of 4,5,6,7-tetrahydro-1H-benzimidazole-5-carboxylic acid and 5,6,7,8-tetrahydroimidazo [1,2-a] pyridine-7-carboxylic acid derivatives designed as inhibitors of TAFIa has been prepared via a common hydrogenation-alkylation sequence starting from the appropriate benzimidazole and imidazopyridine system. We present a successful design strategy using a conformational restriction approach resulting in potent and selective inhibitors of TAFIa. The X-ray structure of compound 5 in complex with a H333Y/H335Q double mutant TAFI indicate that the conformational restriction is responsible for the observed potency increase. (c) 2014 Elsevier Ltd. All rights reserved.